Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00001158 · ClinicalTrials.gov registry record
Studies of the Immune Response in Normal Subjects and Patients With Disorders of the Immune System
A clinical trial, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
NCT00001158: Completed study, sponsored by National Cancer Institute (NCI).
NCT00001158 is a clinical trial that has completed, run by National Cancer Institute (NCI). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00001158 has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
Study Summary
The goal of the protocol is to define the normal humoral and cellular immune responses to antigens in volunteers and to define abnormalities of these immune responses in patients with immunodeficiency diseases or cancer. In vitro assays and in vivo skin tests and immunization with antigens will be utilized.
Trial Details
| Field | Value |
|---|---|
| Start Date | 1977-04 |
| Est. Completion | 2000-03 |
What the finished NCT00001158 record still lists
NCT00001158 is an observational study that tracks outcomes without assigning an intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 0 interventions.
NCT00001158 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00001158 about?
NCT00001158 is a clinical study titled "Studies of the Immune Response in Normal Subjects and Patients With Disorders of the Immune System". The goal of the protocol is to define the normal humoral and cellular immune responses to antigens in volunteers and to define abnormalities of these immune responses in patients with immunodeficiency diseases or cancer. In vitro assays and in vivo skin tests and immunization with antigens will be u...
What is the current status of trial NCT00001158?
This trial is currently completed. The study started on 1977-04. Estimated completion is 2000-03.
Who is sponsoring clinical trial NCT00001158?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia